BioSpace News Archive

BioForest

EndoGastric Solutions Debuts EsophyX Z+ Device for Transoral Incisionless Fundoplication (TIF) Procedures

New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes..

November 29, 2017

·

5 min read

Pharm Country

OncLive Presents State of the Science Summit: Gastrointestinal Malignancies

The event features oncology experts from Memorial Sloan Kettering Cancer Center

November 29, 2017

·

2 min read

Job Trends

BioTalent Canada Announces an Additional $2.3M in Wage Subsidies to Place 200 New Graduates into ‘Green’ Jobs

The federally-funded program will provide $2.3 million in wage subsidies to facilitate over 200 new placements over the next two years.

November 29, 2017

·

2 min read

Genetown

Glytec Integrates With Onduo Virtual Diabetes Clinic

The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.

November 29, 2017

·

3 min read

Drug Development

Aeglea BioTherapeutics Doses First Pediatric Patient with Arginase 1 Deficiency in its Phase I/II Trial with Pegzilarginase (AEB1102)

Clinical agreement reached with FDA to enable pediatric dosing.

November 29, 2017

·

5 min read

Drug Development

Protalix BioTherapeutics Completes Enrollment in Phase II Clinical Trial of OPRX-106 in Patients With Ulcerative Colitis

The Company expects to report top-line results from this study in the first quarter of 2018.

November 29, 2017

·

5 min read

Drug Development

U.S. FDA Grants Fast Track Designation for Idera Pharmaceuticals’ IMO-2125 in Combination with Ipilimumab for Treatment of PD-1 Refractory Metastatic Melanoma

FDA’s Fast Track program is designed to expedite the development and review of drugs and biologics to treat serious or life-threatening conditions.

November 29, 2017

·

6 min read

Deals

Emerald Health Therapeutics Acquires Shares of Vanc Pharmaceuticals

Each whole warrant entitles the holder thereof to purchase one additional Share for a period of 60 months at an exercise price of $0.20.

November 29, 2017

·

4 min read

Drug Development

Aviragen Therapeutics Announces Completion of Patient Enrollment in Phase II Clinical Trial of Teslexivir (BTA074) for the Treatment of Condyloma

The Company expects to report top-line data from this trial in the second quarter of 2018.

November 29, 2017

·

9 min read

Drug Development

Peer-Reviewed Article Published on Pluristem’s PLX-PAD Cells’ Mechanism of Action to Restore Blood Flow in Ischemic Tissue

Data supports advanced PLX-PAD clinical studies including dosing regimen, systemic therapeutic effects and superiority of the cells over cytokines.

November 29, 2017

·

5 min read